Astellas to Establish a New Manufacturing Facility for API of Prograf in Toyama Technology Center

 Astellas to Establish a New Manufacturing Facility for API of Prograf in Toyama Technology Center

Astellas to Establish a New Manufacturing Facility for API of Prograf in Toyama Technology Center

Shots:

  • Astellas will construct the Third Fermentation Building as the manufacturing facility for API of Prograf (tacrolimus hydrate) in the Toyama Technology Center of Astellas Pharma
  • The establishment of the new facility will enhance Astellas’ production capacity, enabling the stable supply of Prograf in future
  • The total construction cost of the facility will be ~$90M with three above-ground floors having a total floor area of ~ 7,220 m2. The construction is expected to be initiated in Apr’20 with its anticipated completion in Aug’21

Click here ­to­ read full press release/ article | Ref: Astellas  | Image: Global Pharma Update

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post